bullish

WuXi AppTec

WuXi AppTec (2359 HK): In-Line 2024 Performance; Announces Dividend and A Share Buyback Plan

466 Views18 Mar 2025 00:30
​WuXi AppTec reports 5% revenue growth in 2024, excluding Covid-19 projects, announces dividends, and proposes buyback plan. Expects 10–15% growth in 2025 with total revenue target of RMB41.5–43.0B.
What is covered in the Full Insight:
  • Introduction to WuXi AppTec's 2024 Performance
  • Financial Highlights and Segment Analysis
  • Order Backlog and Client Growth
  • Capacity Expansion Plans
  • Conclusion and Market Comparison
Boomeranged on Tue, 29 Apr 2025 13:48
1Q25 resumes double-digit growth, with revenue growing 21% YoY and net profit increasing 40% YoY. Growth was driven by Wuxi Chemistry segment. U.S. revenue is up 28%. Gross profit margin is back to normal level (41.9%). Backlog is up 47% YoY (added RMB 3B during 1Q25). Reiterated 2025 revenue growth guidance of 10–15% YoY. No mention of tariff impact. Continue to hold.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Health CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • WuXi AppTec (2359 HK): In-Line 2024 Performance; Announces Dividend and A Share Buyback Plan
    18 Mar 2025
x